Background-Left bundle branch block (LBBB) influences on regional left ventricular (LV) structure, perfusion, and metabolism have not yet been thoroughly investigated in dilated cardiomyopathy patients. Methods and Results-Eleven dilated cardiomyopathy patients with LBBB (meanϮSD age, 62Ϯ11 years; LV ejection fraction, 35Ϯ8%) and 7 dilated cardiomyopathy patients without LBBB (meanϮSD age, 58Ϯ9 years; LV ejection fraction, 37Ϯ10%) were studied by cardiac magnetic resonance and positron emission tomography. The left ventricle was divided in 3 regions: septum, adjacent (anterior-inferior walls), and lateral. Regional midwall circumferential strain, maximum shortening, and strain rate were obtained from tagged cardiac magnetic resonance. The systolic stretch index was calculated as positive strain rate (stretching) divided by total strain rate. Myocardial metabolic rate of glucose and resting and hyperemic myocardial blood flow were quantified by 2-[ 18 F]fluoro-2-deoxyglucose and [ 13 N]ammonia positron emission tomography, respectively. Compared with non-LBBB patients, LBBB patients showed a highly inhomogeneous systolic deformation pattern that changed gradually, moving from a discoordinate [(systolic stretch index, 0.485 (0.284)] and poorly contracting (maximum shortening, Ϫ1.14Ϯ0.96%) septum to a coordinate [systolic stretch index, 0.002 (0.168)] and strongly contracting (maximum shortening, Ϫ13.63Ϯ2.58%) lateral region (both PϽ0.0001). This pattern was closely matched to the myocardial metabolic rate of glucose, disclosing lowest, intermediate, and highest values in the septum, adjacent, and lateral regions, respectively (PϽ0. 0001) . Septal-to-lateral thickness ratio was lower in LBBB than in non-LBBB patients (Pϭ0.03). In both groups, the LV distribution of resting and hyperemic myocardial blood flow and myocardial blood flow reserve did not differ significantly. Conclusions-In dilated cardiomyopathy patients, the extensive LV contraction abnormalities induced by LBBB cause regional myocardial metabolic and structural remodeling, without consistent changes in blood flow. (Circ Cardiovasc Imaging. 2010;3:482-490.)
I n dilated cardiomyopathy (DCM) patients, left bundle branch block (LBBB) occurs frequently and is associated with high cardiac morbidity and mortality. 1 LBBB induces inhomogeneous activation and deformation of the ventricles, leading to inefficient contraction. Experimental data suggest that the redistribution of local workload induced by LBBB provokes substantial changes in regional myocardial blood flow (MBF) 2,3 and glucose metabolism, 3 along with structural remodeling. 4 Studies performed in DCM patients show a global reduction of resting MBF and coronary flow reserve 5 as well as a shift from fatty acid oxidation to glucose utilization. 6 -8 However, in DCM patients with LBBB, data on regional myocardial perfusion are conflicting 9 -13 , whereas 2-[ 18 F]fluoro-2-deoxyglucose ([ 18 F]FDG) positron emission tomography (PET) imaging shows a relative reduction of glucose uptake in the septum compared with the lateral wall 10, 11 but without conclusive quantitative data on regional myocardial glucose metabolism. Deeper insight into the pathophysiologic changes induced by LBBB is warranted to better understand the potential causes of the adverse struc-tural, functional, and metabolic myocardial remodeling, as well as of successful or failing resynchronization therapy. Accordingly, we investigated the influence of a dyssynchronous contraction pattern on regional myocardial structure, perfusion, and metabolism by comparing DCM patients with LBBB and without LBBB who showed a similar degree of left ventricular (LV) dysfunction. Regional and global LV contraction patterns were evaluated by high temporal resolution tagged cardiac magnetic resonance (CMR), whereas MBF and glucose metabolism were quantified by PET imaging with [ 13 N]ammonia and [ 18 F]FDG as flow and metabolic tracers, respectively.
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Methods
Study Population
Between February 2008 and June 2009, 11 patients with DCM and LBBB and 7 DCM patients without LBBB were prospectively studied by CMR and PET. Inclusion criteria were as follows 5 : (1) LV ejection fraction Ͻ50% on transthoracic echocardiography in the absence of previous heart failure symptoms or recent history of mild to moderate heart failure symptoms (New York Heart Association class II or III) stable with oral medications and (2) absence of coronary artery stenosis on invasive angiography. 14 Exclusion criteria were diabetes, atrial fibrillation, acute myocarditis, infiltrative or moderate to severe valvular heart disease (based on echocardiographic evaluation), renal failure, and contraindications to CMR. The protocol was approved by the institutional ethics committee, and all patients gave written, informed consent.
Electrocardiography
LBBB was defined as a QRS duration Ն120 ms, presence of notched R waves in lateral precordial leads (V5 and V6) and I and aVL, small or absent initial r waves in right precordial leads (V1 and V2) followed by deep S waves, absent septal q waves in left-sided leads, and a prolonged intrinsicoid deflection (Ͼ60 ms) in V5 and V6.
Cardiac Magnetic Resonance
All patients were examined with a 1.5-T scanner (CVi, GE Healthcare, Milwaukee, Wis) before PET imaging. Studies were performed with dedicated cardiac software, a phased-array surface receiver coil, and ECG-vectorcardiogram triggering. LV function was assessed by breath-hold, steady-state free-precession cine CMR in the cardiac short-axis and 2-chamber and 4-chamber long-axis views. In the cardiac short-axis view, the left ventricle was completely encompassed by contiguous 8-mm-thick slices. To determine the timing of mitral and aortic valves, high temporal resolution cine CMR in a 3-chamber long-axis view was obtained by setting the number of cardiac phases to achieve a temporal resolution of 12 ms. To investigate wall thickness abnormalities, 3 base-to-apex short-axis cine CMR slices (basal-middle-apical) were also acquired. Sequence parameters were as follows: field-of-viewϭ380 mm, repetition time/echo timeϭ3.2 ms/1.6 ms, ␣ϭ60°, matrixϭ224ϫ192, and number of phasesϭ30 (except for high temporal resolution 3-chamber cine CMR). Tagged CMR was acquired with a segmented gradient-echo pulse sequence, 15 and a nonselective radiofrequency pulse separated by spatial modulation of magnetization-encoding gradients was used to achieve a tag separation of 7 mm. Three base-to-apex short-axis slices were planned by using the same geometry as the 3 short-axis cine CMR (basal-middle-apical), and 2 sets of identical tag lines were acquired for each short-axis slice (the second set was rotated by 90°). The number of cardiac phases was set to obtain a temporal resolution of 12 ms and was identical for both tag line sets. Other sequence parameters were as follows: field-of-viewϭ380 mm, slice thicknessϭ8 mm, repetition time/echo timeϭ6.5 ms/2.3 ms, ␣ϭ15°, and matrixϭ256ϫ160. After admin-istration of 0.2 mmol/kg gadodiamide, a segmented inversionrecovery gradient-echo pulse sequence was used to identify and quantify myocardial late gadolinium enhancement. In the short-axis orientation, the left ventricle was completely encompassed by contiguous 8-mm-thick slices. Images were also acquired in 2-chamber and 4-chamber long-axis views. Late gadolinium enhancement imaging was started 10 minutes after contrast administration, and inversion time was individually adapted to suppress the signal of normal remote myocardium (typical range, 250 to 300 ms). Sequences parameters were as follows: field of viewϭ380 mm, slice thicknessϭ8 mm, repetition time/echo timeϭ4.6 ms/1.3 ms, ␣ϭ20°, and matrix 256ϫ192. [ 13 N]ammonia and [ 18 F]FDG PET studies were performed (meanϮSD) 4Ϯ1 and 10Ϯ3 days after CMR examination, respectively. All patients were studied after an overnight fast.
Positron Emission Tomography
␤-Blocking agents were discontinued 48 hours before imaging, whereas caffeine and theophylline were withdrawn 24 hours before. Patients were positioned on the bed of the PET-computed tomography scanner (Discovery VCT, GE Healthcare). Heart rate, blood pressure, and 9-lead ECG were continuously monitored. After scout acquisition (120 KVp, 10 mA), a transmission scan (140 KVp, 20 to 30 mA, pitchϭ1.35) was performed. Thereafter, 7.4-MBq/kg body weight (0.2 mCi/kg) of [ 13 N]ammonia was injected intravenously (20 to 30 seconds). Dynamic acquisition in 2D mode was started simultaneously with the tracer injection (20 framesϫ6 seconds, 6 framesϫ30 seconds, and 3 framesϫ300 seconds), followed by static acquisition in 3D mode (1 frameϫ300 seconds). After completion of the baseline study and an additional 15 minutes, patients underwent dipyridamole (0.56 mg/kg IV in 4 minutes) stress testing and [ 13 N]ammonia PET imaging as previously described. 5 On a separate day, an [ 18 F]FDG PET study was performed. 16 Patient preparation, monitoring, positioning, and transmission scans were similar to those of the perfusion study. Under fasting condition, [ 18 F]FDG (260 to 300 MBq IV) was injected (20 to 30 seconds), and dynamic acquisition in 2D mode was started simultaneously (18 framesϫ5 seconds, 3 framesϫ10 seconds, 4 framesϫ30 seconds, 3 framesϫ120 seconds, 2 framesϫ150 seconds, and 7 framesϫ300 seconds), followed by static acquisition in 3D mode (1 frameϫ600 seconds). Venous blood samples were obtained before and 30 and 60 minutes after tracer injection for monitoring plasma glucose concentration.
LV Segmentation for Myocardial Tagging and PET Measurements
For both imaging modalities, the left ventricle was divided into 17 segments according to the American Heart Association classification 17 by using right ventricular-LV insertions and papillary muscles as landmarks. The apex (segment 17) was not included in the analysis, and the 16 segments were grouped into 3 cardiac regions: (1) septum, including segments 2, 3, 8, 9, and 14; (2) adjacent region, including segments 1, 4, 7, 10, 13, and 15; and (3) lateral region, including segments 5, 6, 11, 12, and 16 ( Figure 1 ). Unless stated otherwise, PET and CMR regional data were obtained by averaging the corresponding segmental values.
CMR Analysis
All CMR studies were analyzed off-line on a workstation (Advantage AW 4.4, GE Healthcare) with dedicated cardiac software (MASS version 6, Leiden, The Netherlands) by a single experienced operator. LV volumes, mass, and global function were determined from the stack of short-axis cine images. LV volumes and mass were normalized to body surface area. The ratio of LV end-diastolic volume to LV mass was calculated and used as a measure of global end-diastolic wall stress. 18 End-diastolic images of the 3 short-axis cine CMR slices (basal-middle-apical) were used to determine segmental wall thickness by dividing the myocardium into 6 equal (for basal and middle slices) and 4 (for apical slice) sectors by selecting the inferior right ventricular-LV insertion as a landmark.
The presence of late gadolinium enhancement was determined on postcontrast images, and its extent was automatically calculated on short-axis images as a hyperenhanced region with signal intensity Ͼ6 SD above the mean signal intensity of the remote myocardium, as previously reported for nonischemic cardiomyopathy, 19 and expressed as LV percentage.
Myocardial Tagging Analysis
Three base-to-apex (basal-middle-apical) short-axis tagged CMR images were analyzed off-line with harmonic-phase imaging. 15 Midwall circumferential strain was obtained for all 16 segments during the whole cardiac cycle. During systole, for each patient, global (E peak ) and regional ( peak ) maximum circumferential shortening and systolic stretch index (SSI) 20 were calculated with an automatic custom-made method developed in MATLAB 7.0 (see online-only Data Supplement).
PET Analysis
PET scans were evaluated by a single, experienced operator for measurement of absolute MBF and myocardial metabolic rate of glucose (MMRG). Resting and hyperemic MBF quantifications were successfully achieved in all patients. Measurement of MBF at rest and after intravenous dipyridamole with [ 13 N]ammonia has been described in detail elsewhere. 21 In brief, the left ventricle was divided into 17 segments (segment 17 was not included in further analysis), and the [ 13 N]ammonia data were used to compute absolute regional MBF (mL ⅐ min Ϫ1 ⅐ g Ϫ1 ) with dedicated software (Munich-Heart/NM Software) in combination with a previously validated method. 21 Mean LV MBF was obtained for each study condition by averaging regional MBF in 16 segments. MBF reserve was calculated as the ratio between hyperemic and resting MBF. [ 18 F]FDG uptake quantification was successfully achieved in all but 2 patients (1 in each group) who showed almost no uptake as long as 60 minutes after tracer injection. For determination of MMRG (mol ⅐ min Ϫ1 ⅐ g Ϫ1 ), myocardial and blood-pool time-activity curves were used to perform a Patlak analysis. 22 Data obtained 8 to 10 minutes after [ 18 F]FDG administration (starting from the myocardial and blood-pool time-activity curves intersection) were used to calculate the slope of the Patlak plot and to determine segmental MMRG from a lumped constant value of 1.0 and average blood glucose concentrations measured throughout the FDG study. Mean LV MMRG was computed by averaging the values obtained in 16 segments (segment 17 was excluded). To assess the homogeneity of blood flows and MMRG distribution in the left ventricle, a coefficient of variation was calculated for resting and hyperemic MBF, MBF reserve, and MMRG as the ratio between the SD and mean value of the corresponding measurement.
The segmental flow metabolism relation was analyzed with a method adapted from previous studies for assessment of myocardial viability in patients with ischemic LV dysfunction. 23 After excluding the 2 patients in whom it was not possible to measure FDG uptake, in each LV segment, FDG uptake and resting MBF were expressed respectively as the fraction of FDG uptake (FDG corr ) and MBF (MBF corr ) of the segment demonstrating the highest resting MBF. The segmental flow metabolism relation was expressed as the FDG corr -MBF corr ratio. Segments with a relatively better-preserved resting MBF were chosen with respect to a cutoff value of 0.68 mL ⅐ min Ϫ1 ⅐ g Ϫ1 , resulting from the average of resting MBF in 256 segments (0.48Ϯ0.10 mL ⅐ min Ϫ1 ⅐ g Ϫ1 ; Kolmogorov-Smirnov testϭ0.54, Pϭ0.93) plus 2 SD. In these segments, the FDG corr -MBF corr ratio was 1.00Ϯ0. 13 and was normally distributed (Kolmogorov-Smirnov testϭ0.46, Pϭ0.98). Accordingly, thresholds of 1.26 (meanϩ2 SD) and 0.74 (meanϪ2 SD) were used to identify "mismatch" and "reverse mismatch" segments, respectively.
Statistical Analysis
Continuous data were expressed as meanϮSD or as median (interquartile range), and categorical data, as frequency with percentage. A Kolmogorov-Smirnov test was used to assess continuous data distribution. Comparison of categorical variables between the 2 groups was performed by 2 considered statistically significant. Analyses were performed with SSPS version 13 (SPSS, Chicago, Ill).
Results
Global LV Measurements
Patients with and without LBBB did not differ with respect to clinical characteristics (Table 1) , common CMR variables, and PET-measured blood flow and MBF reserve ( Table 2 ). E peak was normally distributed (Kolmogorov-Smirnov testϭ0.66, Pϭ0.78), whereas LV SSI did not show a normal distribution (Kolmogorov-Smirnov testϭ1.67, Pϭ0.008). Patients with and without LBBB had similar values of E peak , whereas LBBB patients showed greater LV SSI than did non-LBBB patients, denoting a more pronounced inhomogeneity of systolic deformation ( Table 2 ). Resting and hyperemic MBF and MBF reserve did not differ between patients with and without LBBB. Although LV MMRG was similar in the 2 groups, patients with LBBB had a higher MMRG variation coefficient than did patients without LBBB, demonstrating greater regional inhomogeneity in glucose utilization ( Table 2) . LV SSI was correlated positively with the MMRG variation coefficient (Spearman's rhoϭ0.51, Pϭ0.046), whereas no association was observed with variation coefficients for resting MBF (Pϭ0.84), hyperemic MBF (Pϭ0.67), and MBF reserve (Pϭ0.80).
Regional LV Measurements
Regional CMR and PET measurements in the 2 groups are summarized in Table 3 . In LBBB patients, the septum and lateral region tended to be thinner and thicker, respectively, compared with the wall thickness of the corresponding regions in non-LBBB patients, resulting in a lower septal-tolateral wall thickness ratio in LBBB patients than in non-LBBB patients (0.74Ϯ0.14 vs 1.00Ϯ0.08, Pϭ0.03). peak was normally distributed (Kolmogorov-Smirnov testϭ0.82, Pϭ0.51), whereas regional SSI did not show a normal distribution (Kolmogorov-Smirnov testϭ1.49, Pϭ0.024). In LBBB patients compared with non-LBBB patients, peak was reduced in the septum and increased in the lateral region, whereas SSI was higher in the septum and adjacent region. Regional myocardial deformation in 2 representative patients with and without LBBB is shown in Figure 2 . Resting and hyperemic MBF did not differ between the 2 groups, whereas MBF reserve in the septum was higher in LBBB patients than in non-LBBB patients (Pϭ0.046). In LGE, n (%) 6 (54) 3 (43) LGE LBBB patients, MMRG was lower in the septum and higher in the lateral region compared with patients without LBBB ( Table 3) . The semiquantitative analysis of the regional flow-metabolism relation showed that, compared with non-LBBB patients, those with LBBB had more LV "mismatch" segments (nϭ16 vs nϭ52, Pϭ0.005) and "reverse mismatch" patterns (nϭ0 vs nϭ48, PϽ0.0001). In LBBB patients 5 (10%), 5 (10%), and 42 (80%) of 52 segments with flow metabolism "mismatch" and 29 (60%), 14 (29%) and 5 (10%) of 48 segments with flow metabolism "reverse mismatch" were located in the septum, adjacent, and lateral regions, respectively (both PϽ0.0001). In non-LBBB patients, 1 (6%), 8 (50%), and 7 (44%) of 16 segments with a flow metabolism Figure 2A ) and without LBBB ( Figure 2B ). In the first case, the septum undergoes prominent, early passive stretching and nearly absent late shortening, resulting in a high SSI (0.875) and null peak value. The adjacent region shows a certain degree of early passive stretching preceding late shortening, whereas the lateral region displays no early passive stretching, resulting in effective (SSIϭ0) and vigorous ( peak ϭϪ14.6%) systolic shortening. In a patient without LBBB, septal, adjacent, and lateral regions shorten effectively during systole, as denoted by no early systolic stretching and negative peak values.
"mismatch" pattern were located in the septum, adjacent, and lateral regions, respectively (Pϭ0.06). Regional distribution of [ 13 N]ammonia, [ 18 F]FDG uptake, and flow metabolism relation in 2 representative patients with and without LBBB are shown in Figure 3 .
Regional Gradients of Systolic Deformation, Myocardial Perfusion, and Glucose Metabolism in Patients With and Without LBBB
In LBBB patients, regional SSI gradually decreased and peak became progressively more negative from the septum to adjacent and lateral regions. These trends were closely matched to the MMRG distribution, showing lowest, intermediate, and highest values in the septum, adjacent, and lateral regions, respectively (Figure 4) . In contrast, resting and hyperemic MBF and MBF reserve were uniformly distributed across LV regions (Pϭ0.18, Pϭ0.21, and Pϭ0.96, respectively).
In non-LBBB patients, the slight septal-to-lateral gradient of peak was not associated with consistent changes in regional MMRG (Figure 4 ). Resting and hyperemic MBF and MBF reserve were uniformly distributed across LV regions (Pϭ0.20, Pϭ0.25, and Pϭ0.83, respectively).
Discussion
In this study, we have demonstrated that LBBB induces relevant abnormalities in systolic deformation of the LV regions, leading to extensive redistribution of myocardial glucose metabolism and asymmetric LV hypertrophy. Conversely, blood flows and MBF reserve were not influenced by contraction abnormalities and thereby, were uniformly distributed across LV regions in patients with and without LBBB.
Influence of Regional Systolic Deformation Pattern on Myocardial Metabolism and Structural Remodeling
DCM patients with LBBB showed a high septal SSI, indicating that nearly 50% of the entire systolic deformation consisted of early passive stretching. This pattern was associated with low septal peak , denoting a very modest contribution of the septum to global LV contraction. The systolic deformation pattern changed progressively from the septum to adjacent and lateral regions, showing a gradual decrease in SSI (ie, systolic stretching) along with more negative peak values (ie, increase in circumferential shortening). Interestingly, the regional workload redistribution was associated with important changes in glucose utilization, which was lowest in the septum and highest in the lateral region. Notably, an inhomogeneous distribution of peak was also observed in the ventricles without LBBB. This change was qualitatively similar but quantitatively less compared with ventricles of LBBB patients and was not associated with regional changes in MMRG distribution. This finding suggests the presence of a threshold in systolic deformation abnormality above which metabolic derangements occur. In an animal model of LV dysfunction with high-frequency LV free-wall pacing, 24 we observed a diffuse increase in LV glucose utilization compared with baseline but without consistent regional differences. This was likely due to the inability of LV free-wall pacing to cause a sufficient degree of ventricular discoordination, 25 as suggested by a similar magnitude of wall stress in the pacing and opposite site.
We also found that fasting global LV glucose utilization was increased in DCM patients to an extent similar to that observed in DCM patients in previous studies. 6, 7, 26 This metabolic shift is likely the expression of impaired myocardial efficiency and may be detrimental in the long run through 2 main mechanisms: (1) increased oxidative stress, linked to high reliance on glucose as a substrate, 27 and (2) reduced myocardial metabolic reserve. 6 Regionally, we found that LBBB patients showed lower MMRG in the septum and adjacent region compared with the lateral region, but these values were consistently greater than global LV glucose utilization measured in normal subjects under fasting conditions 28 or after a glucose load. 7 On the other hand, the glucose metabolism of the lateral region was prominently enhanced, being even higher than that measured in LV myocardium of normal subjects during exercise, 28 and comparable to MMRG assessed by PET in dysfunctional ventricles after a glucose load. 7 These findings support the concept that the relative reduction of septal [ 18 F]FDG uptake in LBBB ventricles, reported mainly in nonquantitative PET studies, 10, 11 was actually due to a huge increase in absolute glucose utilization of the lateral region rather than a real reduction of septal glucose metabolism.
Interestingly, along with metabolic remodeling, we also observed that the unbalanced distribution of mechanical workload was associated with structural LV remodeling, as denoted by a lower septal-to-lateral wall-thickness ratio in DCM patients with LBBB compared with patients without LBBB. In concordance with previous experimental 4 and clinical 9 data, this finding suggests that in LBBB patients, the redistribution of local workload induced an asymmetric LV hypertrophy. 29
Influence of Regional Systolic Deformation Pattern on Regional Flow and Flow Metabolism Relation
Resting and hyperemic MBF and MBF reserve were globally reduced, as has already been found in DCM populations, 5 but were not influenced by the regional pattern of systolic deformation. These findings are concordant with those reported by Nowak et al, 13 describing a uniform distribution of resting MBF studied by PET in DCM patients with LBBB, but diverge from those of Knaapen et al, 12 who presented decreased resting [ 15 O]water uptake in the septum compared with the lateral wall in dysfunctional left ventricles of patients with LBBB and homogenization after resynchronization therapy. This discrepancy can be explained by (1) differences in the study populations, because in the latter study, 7 of 16 patients had ischemic LV dysfunction; and (2) differences in the kinetic properties of flow tracers. In fact, [ 15 O]water and [ 13 N]ammonia are not equivalent, because the former is directly dependent on MBF, whereas [ 13 N]ammonia uptake depends on both blood flow and active transport across the cardiomyocyte membrane. 30 In our study, it is conceivable that the metabolic component of [ 13 N]ammonia extraction could have partially masked the differences in regional blood flows in DCM patients with LBBB.
We also analyzed PET data by the classic semiquantitative approach commonly used to assess the presence of a regional flow metabolism "mismatch" pattern in ischemic heart disease. 23 In the present study, LBBB patients showed a predominance of "mismatch" in the lateral region and "reverse mismatch" in the septum, compared with patients without LBBB. These findings are in line with previous semiquantitative PET studies 10, 11, 31 that describe "mismatch" and "reverse mismatch" patterns in DCM patients. In earlier studies, however, these patterns were interpreted as hallmarks of myocardial ischemia 31 and reduced septal glucose metabolism, respectively. 10, 11 Our results, obtained by quantitative analysis of PET and CMR data, suggest a somewhat different explanation. In LBBB patients, the septal "reverse mismatch" pattern was associated with a relative but not absolute reduction in glucose metabolism. On the other hand, the lateral region "mismatch" pattern was associated with a marked increase in glucose utilization rather than a reduced resting MBF.
Study Limitations
The study was mainly exploratory, enrolling a small number of patients without a preliminary sample size calculation. Patients underwent CMR and [ 13 N]ammonia and [ 18 F]FDG PET imaging in 3 different sessions but with a short time delay (clinical status, hemodynamic conditions, and medications remained unchanged). In the absence of dedicated software for coregistration of CMR and PET images, LV segmentation was achieved according to standards and the same protocol for each imaging modality. We assessed myocardial glucose metabolism by [ 18 F]FDG PET imaging without glucose loading to better emphasize regional differences in glucose utilization under more physiologic conditions. We did not measure plasma free fatty acid concentrations, which could have influenced myocardial glucose utilization. However, the 2 groups showed comparable global LV glucose metabolism, and they differed only in regional MMRG, which should not be affected by circulating free fatty acid levels. We intentionally enrolled patients without advanced disease to better study the consequences of LBBB on myocardial perfusion, structure, and metabolism. Accordingly, we could not evaluate the potential benefit of resynchronization therapy on those abnormalities. Finally, study findings should be extrapolated with caution to patients with different clinical characteristics.
Conclusions
In DCM patients with LBBB, the marked regional changes in systolic deformation induce asymmetric LV hypertrophy and redistribution of glucose metabolism without consistent vari-ation in myocardial perfusion. In particular, the highly coordinated and vigorously contracting lateral region tends to become thicker, and its metabolism shifts to near-maximal glucose utilization, becoming strongly dependent on this substrate. The uncoordinated and poorly contracting septum tends to become thinner but preserves its metabolic reserve. These regional changes may further promote adverse LV remodeling, leading to such extensive alterations that ultimately cannot be attenuated or eventually reversed by resynchronization therapy. Accordingly, larger studies are warranted to identify CMR/PET patterns that may predict the response to resynchronization therapy in DCM patients with LBBB.
